Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Change in Inventory: 2011-2024

Historic Change in Inventory for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to -$5.3 million.

  • Niagen Bioscience's Change in Inventory rose 553.46% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 496.49%. This contributed to the annual value of -$5.3 million for FY2024, which is 3408.55% down from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Change in Inventory is -$5.3 million, which was down 3,408.55% from -$152,000 recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Change in Inventory registered a high of $1.9 million during FY2021, and its lowest value of -$5.3 million during FY2024.
  • Its 3-year average for Change in Inventory is -$1.5 million, with a median of -$152,000 in 2023.
  • As far as peak fluctuations go, Niagen Bioscience's Change in Inventory spiked by 1,195.95% in 2021, and later tumbled by 3,408.55% in 2024.
  • Yearly analysis of 5 years shows Niagen Bioscience's Change in Inventory stood at $148,000 in 2020, then skyrocketed by 1,195.95% to $1.9 million in 2021, then tumbled by 43.90% to $1.1 million in 2022, then slumped by 114.13% to -$152,000 in 2023, then crashed by 3,408.55% to -$5.3 million in 2024.